$3.87
+0.15 (+4.03%)
Open$3.85
Previous Close$3.72
Day High$3.91
Day Low$3.61
52W High$14.98
52W Low$2.75
Volume—
Avg Volume67.7K
Market Cap138.32M
P/E Ratio—
EPS$-6.12
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+350.9% upside
Current
$3.87
$3.87
Target
$17.45
$17.45
$10.78
$17.45 avg
$19.60
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.99M | 5.19M | 51.72M |
| Net Income | -176,894,495 | -165,511,015 | -16,237,176 |
| Profit Margin | -3,544.0% | -3,366.8% | -31.4% |
| EBITDA | -35,726,351 | -35,284,367 | -19,844,642 |
| Free Cash Flow | — | — | -12,228,215 |
| Rev Growth | -3.8% | -3.8% | -2.8% |
| Debt/Equity | — | — | 1.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $292.82 | -0.59% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $457.93 | -0.95% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $170.26 | +1.60% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $534.20 | -0.67% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $957.76 | +0.56% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.50 | -2.02% | 7.7 | 20.98B |